Iranian Red Crescent Medical Journal

Published by: Kowsar

Clinical Significance of Abnormal Results of Second Trimester Hormones in the Absence of Aneuploidy

Isil Uzun 1 , * , N Cenk Sayın 1 , Cihan Inan 1 , Selen Erzincan 1 , Havva Sutcu 1 and Fusun Varol 1
Authors Information
1 Department of Obstetrics & Gynecology, Faculty of Medicine, Trakya University, Edirne, Turkey
Article information
  • Iranian Red Crescent Medical Journal: April 2018, 20 (4); e64310
  • Published Online: April 30, 2018
  • Article Type: Research Article
  • Received: November 22, 2017
  • Revised: January 26, 2018
  • Accepted: February 24, 2018
  • DOI: 10.5812/ircmj.64310

To Cite: Uzun I, Sayın N C, Inan C, Erzincan S, Sutcu H, et al. Clinical Significance of Abnormal Results of Second Trimester Hormones in the Absence of Aneuploidy, Iran Red Crescent Med J. 2018 ; 20(4):e64310. doi: 10.5812/ircmj.64310.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Ananth CV, Wapner RJ, Ananth S, D'Alton ME, Vintzileos AM. First-Trimester and Second-Trimester Maternal Serum Biomarkers as Predictors of Placental Abruption. Obstet Gynecol. 2017;129(3):465-72. doi: 10.1097/AOG.0000000000001889. [PubMed: 28178056]. [PubMed Central: PMC5367463].
  • 2. Katz VL, Chescheir NC, Cefalo RC. Unexplained elevations of maternal serum alpha-fetoprotein. Obstet Gynecol Surv. 1990;45(11):719-26.
  • 3. Huang T, Hoffman B, Meschino W, Kingdom J, Okun N. Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome. Prenat Diagn. 2010;30(5):471-7. doi: 10.1002/pd.2505. [PubMed: 20440736].
  • 4. Gitlin D, Boesman M. Serum alpha-fetoprotein, albumin, and gamma-G-globulin in the human conceptus. J Clin Invest. 1966;45(11):1826-38. doi: 10.1172/JCI105486. [PubMed: 4162738]. [PubMed Central: PMC292864].
  • 5. Mizejewski GJ. Alpha-fetoprotein Structure and Function: Relevance to Isoforms, Epitopes, and Conformational Variants. Exp Biol M. 2016;226(5):377-408. doi: 10.1177/153537020122600503.
  • 6. Gitlin D, Perricelli A, Gitlin GM. Synthesis of α-fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus. Cancer Res. 1972;32(5):979-82.
  • 7. Morris RK, Cnossen JS, Langejans M, Robson SC, Kleijnen J, Ter Riet G, et al. Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis. BMC Pregnancy Childbirth. 2008;8:33. doi: 10.1186/1471-2393-8-33. [PubMed: 18680570]. [PubMed Central: PMC2533288].
  • 8. Bredaki FE, Sciorio C, Wright A, Wright D, Nicolaides KH. Serum alpha-fetoprotein in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound Obstet Gynecol. 2015;46(1):34-41. doi: 10.1002/uog.14809. [PubMed: 25652769].
  • 9. Bredaki FE, Wright D, Akolekar R, Cruz G, Nicolaides KH. Maternal serum alpha-fetoprotein in normal pregnancy at 11-13 weeks' gestation. Fetal Diagn Ther. 2011;30(4):274-9. doi: 10.1159/000330200. [PubMed: 22156386].
  • 10. Settiyanan T, Wanapirak C, Sirichotiyakul S, Tongprasert F, Srisupundit K, Luewan S, et al. Association between isolated abnormal levels of maternal serum unconjugated estriol in the second trimester and adverse pregnancy outcomes. J Matern Fetal Neonatal Med. 2016;29(13):2093-7. doi: 10.3109/14767058.2015.1075503. [PubMed: 27480207].
  • 11. Sirikunalai P, Wanapirak C, Sirichotiyakul S, Tongprasert F, Srisupundit K, Luewan S, et al. Associations between maternal serum free beta human chorionic gonadotropin (beta-hCG) levels and adverse pregnancy outcomes. J Obstet Gynaecol. 2016;36(2):178-82. doi: 10.3109/01443615.2015.1036400. [PubMed: 26368010].
  • 12. Gross SJ, Phillips OP, Shulman LP, Bright NL, Dungan JS, Simpson JL, et al. Adverse perinatal outcome in patients screen-positive for neural tube defects and fetal Down syndrome. Prenat Diagn. 1994;14(7):609-13. [PubMed: 7526367].
  • 13. Spencer K. Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome. Prenatal Diag. 2000;20(8):652-6. doi: 10.1002/1097-0223(200008)20:8<652::aid-pd882>3.0.co;2-6.
  • 14. Sayin NC, Canda MT, Ahmet N, Arda S, Sut N, Varol FG. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns. Arch Gynecol Obstet. 2008;277(1):47-53. doi: 10.1007/s00404-007-0421-6. [PubMed: 17653738].
  • 15. Gagnon A, Wilson RD, Society Of O, Gynaecologists Of Canada Genetics C. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can. 2008;30(10):918-32. doi: 10.1016/S1701-2163(16)32973-5. [PubMed: 19038077].
  • 16. Morris RK, Cnossen JS, Langejans M, Robson SC, Kleijnen J, ter Riet G, et al. Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: Systematic review and meta-analysis. BMC Pregnancy Childb. 2008;8(1). doi: 10.1186/1471-2393-8-33.
  • 17. Kang JH, Farina A, Park JH, Kim SH, Kim JY, Rizzo N, et al. Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity. Prenat Diagn. 2008;28(8):704-9. doi: 10.1002/pd.1997. [PubMed: 18655226].
  • 18. Cuckle HS, Wald NJ, Lindenbaum RH. Maternal Serum Alpha-Fetoprotein Measurement: A Screening Test for down Syndrome. Lancet. 1984;323(8383):926-9. doi: 10.1016/s0140-6736(84)92389-4.
  • 19. Karsidag AY, Buyukbayrak EE, Kars B, Suyugul U, Unal O, Turan MC. The relationship between unexplained elevated serum markers in triple test, uterine artery Doppler measurements and adverse pregnancy outcome. J Pak Med Assoc. 2010;60(3):181-6. [PubMed: 20225773].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments